|
|||||
|
|
Vitamin D3 supplementation,bone health and quality of life in adults with diabetes and chronic kidney disease: Results of an open label randomized clinical trial |
|
| Authors: | Diana R. Mager Stephanie T. Jackson Michelle R. Hoffmann Kailash Jindal Peter A. Senior |
| Affiliation: | 1. Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada;2. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada;3. Division of Endocrinology, University of Alberta, Edmonton, Alberta, Canada;4. Diabetic Nephropathy Prevention Clinic, Alberta Health Services, Edmonton, Alberta, Canada;5. Northern Alberta Renal Program, Edmonton, Alberta, Canada;6. Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada |
| Abstract: | |
| Keywords: | Cholecalciferol Diabetes Chronic kidney disease Bone health 25(OH)D 25-hydroxyvitamin D 1,25-dihydroxyvitamin D BL baseline visit 3mo three month follow-up visit 6mo six month follow-up visit AE adverse event BMD bone mineral density BSAP bone-specific alkaline phosphatase BTM bone turnover markers CKD chronic kidney disease DM diabetes FGF-23 fibroblast growth factor 23 IU international units NTx N-telopeptide of type I collagen OC osteocalcin QoL quality of life PTH parathyroid hormone SAE serious adverse event vitD vitamin D |
| 本文献已被 ScienceDirect 等数据库收录！ | |